Protecting Human Subjects: First Biennial Report on the Adequacy and Uniformity of Federal Rules and Policies, and Their Implementation for the Protection of Human Subjects in Biomedical and Behavioral Research
United States. President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research
President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1981 - 271 sider
Hva folk mener - Skriv en omtale
Vi har ikke funnet noen omtaler på noen av de vanlige stedene.
Andre utgaver - Vis alle
action activities addition Administration agencies appeal applicable appropriate approved assurance authority awards Biomedical Board Center clinical Commission Committee concerning conducted consent continuing contracts debarment decision Department Department of Health determination Development Director documents drug Education effect established Ethical Federal Federal agencies final findings funds further governing grant Health hearing HHS regulations human subjects identified implementation individual informed consent injuries institution investigator involving human subjects issues legally letter material meeting misconduct notice Office OPRR participation parties performance period persons policies possible present principal prisoners problems procedures programs proposed protection of human questions reasons received recommendations record regarding reports request research involving research with human responsible result risk rules Science Secretary Services specific staff standards statement submitted subpart suspension termination tests tion University visits Washington written
Side 25 - An explanation of whom to contact for answers to pertinent questions about the research and research subjects' rights, and whom to contact in the event of a research-related injury to the subject; and (8) A statement that participation is voluntary, refusal to participate will involve no penalty or loss of benefits to which the subject is otherwise entitled, and the subject may discontinue participation at any time without penalty or loss of benefits to which the subject is otherwise entitled.
Side 95 - A statement that the particular treatment or procedure may involve risks to the subject (or to the embryo or fetus, if the subject is or may become pregnant) which are currently unforeseeable; (2) Anticipated circumstances under which the subject's participation may be terminated by the investigator without regard to the subject's consent; (3) Any additional costs to the subject that may result from participation in the research; (4) The consequences of a subject's decision to withdraw from the research...
Side 95 - A statement describing the extent, if any, to which confidentiality of records identifying the subject will be maintained...
Side 109 - Research involving the collection or study of existing data, documents, records, pathological specimens, or diagnostic specimens, if these sources are publicly available, or if the information is recorded by the investigator in such a manner that subjects cannot be identified, directly or through identifiers linked to the subjects.
Side 113 - A statement that the study involves research, an explanation of the purposes of the research and the expected duration of the subject's participation, a description of the procedures to be followed, and identification of any procedures which are experimental; (2) A description of any reasonably foreseeable risks or discomforts to the subject...
Side 88 - Minimal risk means that the probability and magnitude of harm or discomfort anticipated in the research are not greater in and of themselves than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests.
Side 96 - IRB finds and documents that: (1) The research involves no more than minimal risk to the subjects; (2) The waiver or alteration will not adversely affect the rights and welfare of the subjects; (3) The research could not practicably be carried out without the waiver or alteration; and (4) Whenever appropriate, the subjects will be provided with additional pertinent information after participation.
Side 16 - Private information" includes information about behavior that occurs in a context in which an individual can reasonably expect that no observation or recording is taking place, and information which has been provided for specific purposes by an individual and which the individual can reasonably expect will not be made public (for example, a medical record). Private information must be...
Side 102 - ... and the purpose of the activity is the development of important biomedical knowledge, which cannot be obtained by other means, or 2.
Side 25 - ... medical treatments are available if injury occurs and, if so, what they consist of, or where further information may be obtained; 7. an explanation of whom to contact for answers to pertinent questions about the research and research subjects' rights, and whom to contact in the event of a research-related injury to the subject; and 8.